Lacrimal Gland and Salivary Gland Lesions

  • Motohisa Yamamoto
  • Hiroki Takahashi
  • Yasuhisa Shinomura


Tissue biopsies undertaken to diagnose IgG4-related dacryoadenitis and sialadenitis are of great diagnostic value. Not only do they provide one of the bases for the diagnosis, they also facilitate the differentiation of conditions such as malignant lymphoma. In IgG4-related dacryoadenitis and sialadenitis, as in other types of IgG4-related disease (IgG4-RD), both a marked lymphoplasmacytic infiltrate and fibrosis are characteristic histopathological findings. The plasma cell population within tissue is comprised of an overabundance of IgG4-positive cells, and the IgG4:total IgG ratio is typically in excess of 0.40. Numerous lymph follicles are also found within tissues. Storiform fibrosis and obliterative phlebitis, generally viewed as typical histopathological features of IgG4-RD, are perhaps less common in the salivary and lacrimal glands compared to autoimmune pancreatitis. Thus, some organ-to-organ variability in the pathological features of IgG4-RD is observed.


Salivary Gland Submandibular Gland Lacrimal Gland Minor Salivary Gland Autoimmune Pancreatitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



For assistance with the tissue specimens we would like to express here our deep gratitude to Professor Haruyuki Tatsumi, First Department of Anatomy, Sapporo Medical University School of Medicine, Professor Tadashi Hasegawa, Department of Surgical Pathology, Sapporo Medical University School of Medicine, and Dr. Akira Suzuki, KKR Sapporo Medical Center, Department of Diagnostic Pathology.


  1. 1.
    Takahashi H, Yamamoto M, Suzuki C, Naishiro Y, Shinomura Y, Imai K. The birthday of a new syndrome: IgG4-related diseases constitute a clinical entity. Autoimmun Rev. 2010;9:591–4.PubMedCrossRefGoogle Scholar
  2. 2.
    Umehara H, Okazaki K, Masaki Y, et al. A novel clinical entity, IgG4-related disease (IgG4-RD): general concept and details. Mod Rheumatol. 2012;22:1–14.PubMedCrossRefGoogle Scholar
  3. 3.
    Lindstrom KM, Cousar JB, Lopes MB. IgG4-related meningeal disease: clinico-pathological features and proposal for diagnostic criteria. Acta Neuropathol. 2010;120:765–76.PubMedCrossRefGoogle Scholar
  4. 4.
    Yamamoto M, Takahashi H, Ohara M, et al. A case of Mikulicz’s disease (IgG4-related plasmacytic disease) complicated by autoimmune hypophysitis. Scand J Rheumatol. 2006;35:410–1.PubMedCrossRefGoogle Scholar
  5. 5.
    Plaza JA, Garrity JA, Dogan A, Ananthamurthy A, Witzig TE, Salomão DR. Orbital inflammation with IgG4-positive plasma cells: manifestation of IgG4 systemic disease. Arch Ophthalmol. 2011;129:421–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Yamamoto M, Harada S, Ohara M, et al. Clinical and pathological differences between Mikulicz’s disease and Sjögren syndrome. Rheumatology (Oxford). 2005;44:227–34.CrossRefGoogle Scholar
  7. 7.
    Takahira M, Kawano M, Zen Y, et al. IgG4-related chronic sclerosing dacryoadenitis. Arch Ophthalmol. 2007;125:1575–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Takano K, Yamamoto M, Kondo A, et al. A clinical study of olfactory dysfunction in patients with Mikulicz’s disease. Auris Nasus Larynx. 2011;38:347–51.PubMedCrossRefGoogle Scholar
  9. 9.
    Kitagawa S, Zen Y, Harada K, et al. Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (Küttner’s tumor). Am J Surg Pathol. 2005;29:783–91.PubMedCrossRefGoogle Scholar
  10. 10.
    Dahlgren M, Khosroshahi A, Nielsen GP, Deshpande V, Stone JH. Riedel’s thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res (Hoboken). 2010;62:1312–8.CrossRefGoogle Scholar
  11. 11.
    Kakudo K, Li Y, Hirokawa M, et al. Diagnosis of Hashimoto’s thyroiditis and IgG4-related sclerosing disease. Pathol Int. 2011;61: 175–83.PubMedCrossRefGoogle Scholar
  12. 12.
    Mikulicz J. Über eine eigenartige symmetrishe Erkrankung der Tranen und Mundspeicheldrusen. Beitr z Chir Fesrschr f Theodor Billroth, Stuttgart; 1892. pp 610–30.Google Scholar
  13. 13.
    Schaffer AJ, Jacobsen AW. Mikulicz’s syndrome: a report of ten cases. Am J Dis Child. 1927;34:327–46.CrossRefGoogle Scholar
  14. 14.
    Sjögren H. Zur Kenntnis der Keratoconjunctivitis Sicca. Acta Ophthalmol. 1933; Suppl II:1–151.Google Scholar
  15. 15.
    Morgan WS, Castleman B. A clinicopathologic study of “Mikulicz’s disease”. Amer J Pathol. 1953;29:471–503.Google Scholar
  16. 16.
    Suzuki S, Kida S, Ohira Y, et al. A case of Sjögren’s syndrome accompanied by lymphadenopathy and IgG4 hypergammaglobulinemia. Ryumachi. 1993;33:249–54 (in Japanese).PubMedGoogle Scholar
  17. 17.
    Yamamoto M, Takahashi H, Mizukoshi T, et al. A male case of Sjögren’s syndrome presenting with generalized lymphadenopathy and swelling of both lacrimal and salivary glands which responded remarkably well to an administration of corticosteroids. Nihon Rinsho Meneki Gakkai Kaishi. 2000;23:22–9 (in Japanese).PubMedCrossRefGoogle Scholar
  18. 18.
    Yamamoto M, Ohara M, Suzuki C, et al. Elevated IgG4 concentrations in serum of patients with Mikulicz’s disease. Scand J Rheumatol. 2004;33:432–3.PubMedCrossRefGoogle Scholar
  19. 19.
    Yamamoto M, Takahashi H, Shinomura Y. Mikulicz’s disease and extraglandular lesions. Curr Immunol Rev. 2011;7:162–71.CrossRefGoogle Scholar
  20. 20.
    Yamamoto M, Takahashi H, Hasebe K, et al. The analysis of interleukin-6 in patients with systemic IgG4-related plasmacytic syndrome-expansion of SIPS to the territory of Castleman’s disease. Rheumatology (Oxford). 2009;48:860–2.CrossRefGoogle Scholar
  21. 21.
    Küttner H. Ueber entzündliche tumoren der submaxillar-speicheldruse. Bruns Beitr Klin Chir. 1896;15:815–28.Google Scholar
  22. 22.
    Takano K, Yamamoto M, Takahashi H, Shinomura Y, Imai K, Himi T. Clinicopathological similarities between Mikulicz’s disease and Küttner tumor. Am J Otolaryngol. 2010;31:429–34.PubMedCrossRefGoogle Scholar
  23. 23.
    Tsubota K, Fujita H, Tsuzaka K, Takeuchi T. Mikulicz’s disease and Sjögren’s syndrome. Invest Ophthalmol Vis Sci. 2000;41:1666–73.PubMedGoogle Scholar
  24. 24.
    Notohara K, Wani Y, Fujisawa M. Storiform fibrosis in various organs involved by IgG4-related disease. International symposium on IgG4-related disease; 2011. p 4.Google Scholar
  25. 25.
    Zen Y, Fujii T, Harada K, et al. Th2 and regulatory immune reactions are increased in immunoglobulin G4-related sclerosing pancreatitis and cholangitis. Hepatology. 2007;45:1538–46.PubMedCrossRefGoogle Scholar
  26. 26.
    Tabeya T, Yamamoto M, Naishiro Y, et al. Markedly decreased release of cytotoxic granules causes down-regulation of apoptosis in IgG4-related disease. 2013; in submitted.Google Scholar
  27. 27.
    Takano K, Yamamoto M, Kondo A, Takahashi H, Himi T. A clinical study of olfactory dysfunction in patients with Mikulicz’s disease. Auris Nasus Larynx. 2011;38:347–51.PubMedCrossRefGoogle Scholar
  28. 28.
    Smyrk TC. Pathological features of IgG4-related sclerosing disease. Curr Opin Rheumatol. 2011;23:74–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2014

Authors and Affiliations

  • Motohisa Yamamoto
    • 1
  • Hiroki Takahashi
    • 1
  • Yasuhisa Shinomura
    • 1
  1. 1.Department of Gastroenterology, Rheumatology and Clinical ImmunologySapporo Medical University School of MedicineSapporo CityJapan

Personalised recommendations